| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |